First patients receive experimental cancer drug in new trial
NCT ID NCT06424665
Summary
This is the first study in people to test a new drug called FZ-AD005. The main goals are to find a safe dose and see how the body processes the drug. Researchers will also look for early signs that it might help shrink tumors in patients with advanced cancers, particularly certain types of lung cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR, SCLC(SMALL CELL LUNG CANCER) OR LCNEC (LARGE CELL NEUROENDOCRINE CARCINOMA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hunan Cancer Hospital
RECRUITINGChangsha, Hunan, 410013, China
Contact
-
Shanghai East Hospital
RECRUITINGShanghai, Shanghai Municipality, 200120, China
Contact
-
Zhejiang Cancer Hospital
RECRUITINGHangzhou, Zhejiang, 310022, China
Contact
Conditions
Explore the condition pages connected to this study.